Parmar, A., Timilshina, N., Emmenegger, U., Smoragiewicz, M., Sander, B., Alibhai, S. . and Chan, K. K. (2021) “A cost-utility analysis of apalutamide for metastatic castrationsensitive prostate cancer”, Canadian Urological Association Journal, 16(3), pp. E126–31. doi: 10.5489/cuaj.7495.